Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Specify Company / Ticker to Get the Summary
Internet Computer
ICP
Bitcoin Cash
BCH
Litecoin
LTC
Sensorion SA
ALSENCurrent price
0.70 EUR
+0.01 EUR (+1.45%)
Last closed
0.69 EUR
Company
www.sensorion.com
ISIN
FR0012596468
Sector
Healthcare
Industry
Biotechnology
Exchange
Euronext Paris
Capitalization
211 328 662 EUR
Yield for 12 month
+41.27 %
1Y
3Y
5Y
10Y
15Y
ALSEN
Sensorion SA, a biotechnology company, develops drug candidates for the treatment of inner ear disorders in France. Its pipeline includes various products in the development stage for restoring, treating, and preventing inner ear related disorders. The company's product portfolio includes SENS-401 SSNHL, which has completed Phase 2 clinical trial for the treatment of Sudden Sensorineural Hearing Loss; SENS-401 CIO that is in Phase 2 clinical trial for the treatment of Cisplatin-Induced Ototoxicity; and SENS-401 Cochlear, which is in Phase 2 clinical trial for the treatment of hearing preservation after cochlear implantation. It is also developing OTOF-GT (SENS-501), a gene therapy development program that has completed Phase 1 clinical trial to restore hearing in people living with Otoferlin deficiency; and GJB2-GT, a gene therapy development program, which is in pre-clinical trial to restore hearing in people living with hearing loss due to mutations in the GJB2 gene. The company was incorporated in 2009 and is headquartered in Montpellier, France. Address: 375, rue du Professeur Joseph Blayac, Montpellier, France, 34080
Check your investment idea
Find the best to beat the market
TSLA
Tesla Motors
AAPL
Apple
MSFT
Microsoft
Analytics
WallStreet Target Price
2.43 EURP/E ratio
–Dividend Yield
–Current Year
+4 729 749 EUR
Last Year
+4 919 804 EUR
Current Quarter
+3 126 199 EUR
Last Quarter
+3 002 713 EUR
Current Year
+3 777 229 EUR
Last Year
+4 151 486 EUR
Current Quarter
+2 558 797 EUR
Last Quarter
+2 525 340 EUR
Key Figures ALSEN
1 year
3 years
5 years
10 years
EBITDA
-24 010 214 EUR
Operating Margin TTM
PE Ratio
–
Return On Assets TTM
-24.67 %
PEG Ratio
–
Return On Equity TTM
-50.73 %
Wall Street Target Price
2.43 EUR
Revenue TTM
6 128 947 EUR
Book Value
0.28 EUR
Revenue Per Share TTM
Dividend Share
–
Quarterly Revenue Growth YOY
22.70 %
Dividend Yield
–
Gross Profit TTM
6 128 947 EUR
Earnings per share
-0.070 EUR
Diluted Eps TTM
-0.070 EUR
Most Recent Quarter
II 2024
Quarterly Earnings Growth YOY
–
Profit Margin
–
Dividend Analytics ALSEN
Max Ratio
>10 - expected double digit dividend yield on cost over 10Y >5 - expected 5-9 dividend yield on cost over 10Y <5 - expected <5 dividend yield on cost over 10Y MaxRatio is an estimated 10Y dividend yield on cost calculated by combining the current dividend yield with the 5-year & 10-year average dividend growth rate, projected over the next 10 years discounted based on current Financial Score. It provides a projected outlook on future dividend returns.
–5Y Dividend Growth
–Consecutive Years
–5Y Average Payout Ratio
–Dividend History ALSEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate
–
Ex Dividend Date
–
Forward Annual Dividend Yield
–
Last Split Factor
–
Payout Ratio
–
Last Split Date
–
Dividend Date
–
Stock Valuation ALSEN
1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE
–
Forward PE
–
Enterprise Value Revenue
22.62
Price Sales TTM
34.48
Enterprise Value EBITDA
-7.70
Price Book MRQ
2.47
Financials ALSEN
1 year
3 years
5 years
10 years
15 years
| Results | 2019 | Dynamics |
* The data for this period has not yet been published
Technical indicators ALSEN
For 52 weeks
0.46 EUR
1.04 EUR
50 Day MA
0.67 EUR
Shares Short Prior Month
–
200 Day MA
0.71 EUR
Short Ratio
–
Shares Short
–
Short Percent
–
BeatStart